Pancragen
Khavinson-series peptide for pancreatic tissue — limited evidence.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About Pancragen
Pancragen is a synthetic short peptide from the Khavinson 'bioregulator' series, proposed to act on the pancreas and glucose metabolism. The tissue-specific bioregulator concept — that short peptides normalize protein synthesis in a target organ — is a research hypothesis, not an established mechanism. Compound-specific published research is scarce: Pancragen is described mainly within the broader bioregulator literature rather than in dedicated trials, so its effects in humans are unverified. It is not approved by any regulator and is sold for research use only.
Key Benefits
- Proposed to act on pancreatic tissue (hypothesis-stage)
- Part of the Khavinson tissue-specific peptide series
- Little compound-specific published evidence
- Effects not demonstrated in controlled human trials
Set a goal (top of the page) to see how Pancragen scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- No formal independent human safety data
- Originating group reports low toxicity in studies
- Injection-site reactions (typical of subcutaneous peptides)
Legal & Regulatory Status
Research use only. Not approved by the FDA or EMA for human use. Compound-specific evidence is scarce and concentrated in a single research lineage.
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
Sources are selected for reliability (peer-reviewed literature, openFDA, ClinicalTrials.gov) but this is a research summary, not medical advice, and may not be exhaustive.
Prices at quality-checked sources · as of July 2026 (3 weeks ago)
- $61.48
Observed on each vendor’s public listing — see how these sources are vetted. Peptide Concierge doesn’t sell peptides and isn’t affiliated with any vendor; confirm current pricing at the source.
Builds a working set shared across the stack builder, calculator, scheduler and compare.